Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin add-on in chronic schizophrenia
NCT02298985Phase 4Completed
- Sponsor
- Be'er Sheva Mental Health Center
- Start
- Jan 2015
- Primary completion
- Jan 2017
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of curcumin in schizophrenia, sponsored by Be'er Sheva Mental Health Center. Started Jan 2015; status: completed.
02
Drugs
curcumin
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT02298985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02298985.